Eisai Refiles Mecobalamin For ALS In Japan After Seven Years

If approved, mecobalamin can expand the treatment option for early ALS patients.
mecobalamin would expand ALS options in Japan if approved • Source: Shutterstock

More from Japan

More from Focus On Asia